首页> 外国专利> Synthesis of oseltamivir-containing phosphonate congeners with anti-influenza activity

Synthesis of oseltamivir-containing phosphonate congeners with anti-influenza activity

机译:具有抗流感活性的含奥司他韦的膦酸酯同类物的合成

摘要

Novel phosphonate compounds are described. The compounds have activity as neuraminidase inhibitors against wild-type and H274Y mutant of H1N1 and H5N1 viruses. The present disclosure also provides an enantioselective synthetic route to known neuraminidase inhibitors oseltamivir and the anti-flu drug Tamiflu®, as well as novel phosphonate compounds, via D-xylose. Another efficient and flexible synthesis of Tamiflu and the highly potent neuraminidase inhibitor Tamiphosphor was also achieved in 11 steps and 20% overall yields from the readily available fermentation product (1S-cis)-3-bromo-3,5 -cyclohexadiene-1,2-diol. Most of the reaction intermediates were obtained as crystals without tedious purification procedures. The key transformations include an initial regio- and stereoselective bromoamidation of a bromoarene cis-dihydrodiol, as well as the final palladium-catalyzed carbonylation and phosphonylation.
机译:描述了新型膦酸酯化合物。该化合物作为神经氨酸酶抑制剂具有抗H1N1和H5N1病毒的野生型和H274Y突变体的活性。本公开还提供了经由D-木糖与已知神经氨酸酶抑制剂奥司他韦和抗流感药以及新的膦酸酯化合物的对映体选择性合成途径。从易于获得的发酵产物(1S-顺式)-3-溴-3,5-环己二烯-1中,分11步完成了达菲和高效神经氨酸酶抑制剂Tamiphosphor的另一种高效,灵活的合成,总收率> 20%, 2-二醇。无需繁琐的纯化程序即可获得大多数反应中间体的晶体。关键的转化包括溴芳烃顺式-二氢二醇的初始区域和立体选择性溴酰胺化,以及最终的钯催化的羰基化和膦酰化。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号